IU cancer center findings could reduce treatment-related complication for blood cancer patients

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center published a study in the New England Journal of Medicine on preventing a common complication to lifesaving blood stem cell transplantation in leukemia.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

When conducting a randomized clinical trial of a treatment regimen based on an immune checkpoint inhibitor, trial sponsors should include overall survival as an endpoint, FDA officials say.

Login